Abstract
Hemodynamic effects of morphine and the new narcotic analgesic, nalbuphine, were compared in a randomized, double-blind study in 15 patients with acute myocardial infarction (11 men and four women, average age 56.2 yr) and normal group mean hemodvnamic,function. During a 1-hr evaluation the Hmodynamic effects were small but there were changes in several parameters. Morphine reduced heart rate (78 to 72 bpm, p < 0.01) and diastolic and mean arterial pressures (69 to 64 mm Hg, p < 0.05; and 91 to 84 nun Hg, p < 0.05); nalbuphine was associated with a decrease in heart rate (82 to 72 bpm, p < 0.01), decrease in cardiac index, which remained within the normal range (3.16 to 2.75 lminlinz, p < 0.01), and an increase in systemic vascular resistance (1,204 to 1,461 dynes · sec · cm-5 p < 0.05). Neither drug altered systolic arterial pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, stroke index, stroke work index, or pulmonary vascular resistance. Echocardiographic assessment revealed diminution of left ventricular mean velocity gf circumferential fiber shortening sifter nalbuphine (1.26 to 1.08 circlsec, p < 0.05). Both drugs induced small reductions in respiratory rate and arterial pH and increases in PAO2 There were no changes in PaO2. Because of the absence of clinically important deleterious effects on cardiac pump function, nalbuphine merits further investigation as an analgesic in acute myocardial infarction.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 576-581 |
| Number of pages | 6 |
| Journal | Clinical Pharmacology and Therapeutics |
| Volume | 29 |
| Issue number | 5 |
| State | Published - May 1981 |
Fingerprint
ASJC Scopus subject areas
- Pharmacology
Cite this
Hemodynamic effects of morphine and nalbuphine in acute myocardial infarction. / Lee, Garrett; Low, Reginald; Amsterdam, Ezra A; DeMaria, Anthony N.; Huber, Paula W.; Mason, Dean T.
In: Clinical Pharmacology and Therapeutics, Vol. 29, No. 5, 05.1981, p. 576-581.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Hemodynamic effects of morphine and nalbuphine in acute myocardial infarction
AU - Lee, Garrett
AU - Low, Reginald
AU - Amsterdam, Ezra A
AU - DeMaria, Anthony N.
AU - Huber, Paula W.
AU - Mason, Dean T.
PY - 1981/5
Y1 - 1981/5
N2 - Hemodynamic effects of morphine and the new narcotic analgesic, nalbuphine, were compared in a randomized, double-blind study in 15 patients with acute myocardial infarction (11 men and four women, average age 56.2 yr) and normal group mean hemodvnamic,function. During a 1-hr evaluation the Hmodynamic effects were small but there were changes in several parameters. Morphine reduced heart rate (78 to 72 bpm, p < 0.01) and diastolic and mean arterial pressures (69 to 64 mm Hg, p < 0.05; and 91 to 84 nun Hg, p < 0.05); nalbuphine was associated with a decrease in heart rate (82 to 72 bpm, p < 0.01), decrease in cardiac index, which remained within the normal range (3.16 to 2.75 lminlinz, p < 0.01), and an increase in systemic vascular resistance (1,204 to 1,461 dynes · sec · cm-5 p < 0.05). Neither drug altered systolic arterial pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, stroke index, stroke work index, or pulmonary vascular resistance. Echocardiographic assessment revealed diminution of left ventricular mean velocity gf circumferential fiber shortening sifter nalbuphine (1.26 to 1.08 circlsec, p < 0.05). Both drugs induced small reductions in respiratory rate and arterial pH and increases in PAO2 There were no changes in PaO2. Because of the absence of clinically important deleterious effects on cardiac pump function, nalbuphine merits further investigation as an analgesic in acute myocardial infarction.
AB - Hemodynamic effects of morphine and the new narcotic analgesic, nalbuphine, were compared in a randomized, double-blind study in 15 patients with acute myocardial infarction (11 men and four women, average age 56.2 yr) and normal group mean hemodvnamic,function. During a 1-hr evaluation the Hmodynamic effects were small but there were changes in several parameters. Morphine reduced heart rate (78 to 72 bpm, p < 0.01) and diastolic and mean arterial pressures (69 to 64 mm Hg, p < 0.05; and 91 to 84 nun Hg, p < 0.05); nalbuphine was associated with a decrease in heart rate (82 to 72 bpm, p < 0.01), decrease in cardiac index, which remained within the normal range (3.16 to 2.75 lminlinz, p < 0.01), and an increase in systemic vascular resistance (1,204 to 1,461 dynes · sec · cm-5 p < 0.05). Neither drug altered systolic arterial pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, stroke index, stroke work index, or pulmonary vascular resistance. Echocardiographic assessment revealed diminution of left ventricular mean velocity gf circumferential fiber shortening sifter nalbuphine (1.26 to 1.08 circlsec, p < 0.05). Both drugs induced small reductions in respiratory rate and arterial pH and increases in PAO2 There were no changes in PaO2. Because of the absence of clinically important deleterious effects on cardiac pump function, nalbuphine merits further investigation as an analgesic in acute myocardial infarction.
UR - http://www.scopus.com/inward/record.url?scp=0019409412&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019409412&partnerID=8YFLogxK
M3 - Article
VL - 29
SP - 576
EP - 581
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
SN - 0009-9236
IS - 5
ER -